Identification of Therapeutic Targets in Rhabdomyosarcoma Through Integrated Genomic, Epigenomic, and Proteomic Analyses.
Elizabeth Stewart,Justina McEvoy,Hong Wang,Xiang Chen,Victoria Honnell,Monica Ocarz,Brittney Gordon,Jason Dapper,Kaley Blankenship,Yanling Yang,Yuxin Li,Timothy I. Shaw,Ji-Hoon Cho,Xusheng Wang,Beisi Xu,Pankaj Gupta,Yiping Fan,Yu Liu,Michael Rusch,Lyra Griffiths, Jongrye Jeon, Burgess B. Freeman,Michael R. Clay, Alberto Pappo, John Easton, Sheila Shurtleff, Anang Shelat, Xin Zhou, Kristy Boggs, Heather Mulder, Donald Yergeau, Armita Bahrami, Elaine R. Mardis, Richard K. Wilson, Jinghui Zhang, Junmin Peng, James R. Downing, Michael A. Dyer Cancer Cell（2018）
Key words
epigenetics,molecular targeted therapy,proteomics,preclinical testing,rhabdomyosarcoma,pediatric cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper